Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agent and method for treating disorders associated with cytidine deaminase or deoxycytidine deaminase overexpression

Agent and method for treating disorders associated with cytidine deaminase or deoxycytidine deaminase overexpression

US Patent 6136791 · Granted Oct 24, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition and method for altering levels of or sensitivity to adenosine with a2011
Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary 2008
Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatme2006
Composition, formulations & method for prevention & treatment of diseases and co2004
Composition & method for altering levels of or sensitivity to adenosine with a d2003
Method of treating disorders characterized by overexpression of cytidine deamina2002
Satiety inducing composition comprising Neuropeptide Y analogues and methods of 2002
Method for reducing adenosine levels with a dehydroepiandrosterone and optionall2000
Neuropeptide Y analogues, compositions and methods of lowering blood pressure2000
Specific antisense oligonucleotide composition & method for treatment of disorde2000
Composition, kit and method for treatment of disorders associated with bronchoco2000
Low adenosine agent, composition, kit and method for treatment of airway disease1999